On October 11 in Carlsbad, California, Managing Partner Erik Clausen will lead a group of cell and gene therapy leaders to discuss best practices in manufacturing at the preeminent industry conference. The “Simplifying the Pathway to Early-phase ATMP Manufacturing” session will feature senior leaders from Azzur Group, Elevate Bio, Editas Medicine, and Vitrian exploring ways to accelerate time to clinic for new therapies.